Alerts will be sent to your verified email
Verify Email
POSITRON
|
Positron Energy
|
TCI Industries
|
Novelix Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
28.49 % | 0.0 | 0.0 |
|
5yr average Equity Multiplier
|
2.58 | 1.22 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
2.01 | 0.11 | 0.84 |
|
5yr Avg Net Profit Margin
|
5.86 % | -125.14 % | -14.11 % |
|
Price to Book
|
0.0 | 8.19 | 14.73 |
|
P/E
|
6.41 | 0.0 | 58.07 |
|
5yr Avg Cash Conversion Cycle
|
12.01 Days | 2.9 Days | 29.1 Days |
|
Inventory Days
|
14.67 Days | 0.0 | 34.04 Days |
|
Days Receivable
|
25.28 Days | 2.9 Days | 55.38 Days |
|
Days Payable
|
26.53 Days | 10.52 Days | 55.7 Days |
|
5yr Average Interest Coverage Ratio
|
12.35 | -13.57 | -17.77 |
|
5yr Avg ROCE
|
25.69 % | -10.1 % | -15.4 % |
|
5yr Avg Operating Profit Margin
|
7.82 % | -117.69 % | -16.49 % |
|
5 yr average Debt to Equity
|
0.7 | 0.07 | 0.05 |
|
5yr CAGR Net Profit
|
138.58 % | 7.5 % | 35.78 % |
|
5yr Average Return on Assets
|
11.43 % | -9.48 % | -13.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.04 % | 69.51 % | 51.98 % |
|
Share Pledged by Promoters
|
0.0 | 7.22 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | 0.32 % | -14.94 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Positron Energy
|
TCI Industries
|
Novelix Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|